American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The median citation count of American Journal of Clinical Oncology-Cancer Clinical Trials is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer40
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer30
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer28
Concurrent Nab-paclitaxel and Radiotherapy24
Meta-analysis of Targeted Therapies in EGFR-mutated Non–Small Cell Lung Cancer22
Assessment of Radiotherapy as a Standalone Treatment Following Neoadjuvant Chemotherapy in Nonmetastatic Breast Cancer21
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients19
Impact of Age on Overall Survival Among Children With Wilms Tumor14
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer13
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer13
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures11
Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma10
Is There a Role for Perioperative Pelvic Radiotherapy in Surgically Resected Stage IV Rectal Cancer?10
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies9
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?9
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer9
The Influence of Hospital Characteristics on Patient Survival in Surgically Managed Metastatic Disease of Bone9
Sacituzumab Govitecan-hziy in Breast Cancer8
Sepsis Hospitalizations With Versus Without Cancer8
Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections8
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry8
Accelerated Partial Breast Irradiation8
Cardiac Angiosarcomas8
Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia8
Reirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma7
Long-term Locoregional Control With Unilateral Radiation for AJCC-7 T1-2N2b Tonsillar Cancer7
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers7
Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?7
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status7
Treatment Patterns, Toxicity, and Outcomes of Older Adults with Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy: Erratum7
Proceedings of the American Radium Society®’s 103rd Annual Meeting7
Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer7
Rectosigmoid Cancer—Rectal Cancer or Sigmoid Cancer?7
Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases7
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy6
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases6
Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival6
Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors6
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma6
Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease6
An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation6
Bombarding Oligoprogression6
Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer6
Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients5
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage5
Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection5
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy5
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia5
Geographic Disparities in Access to Cancer Clinical Trials in Canada5
Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases5
Accelerated Partial Breast Irradiation5
A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer5
Radiation Proctitis in Patients With Locally Advanced Cervical Cancer Treated by Chemoradiation5
Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma5
Unknown Causes of Death in Cancer Patients4
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy4
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer4
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer4
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors4
Prognostic Relevance of Negative Lymph Node Count in Resected Stage I–IIIa Small-cell Lung Cancer4
Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees4
A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mut4
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer4
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease4
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer4
Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy4
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy4
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast4
Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors3
Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer3
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation3
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer3
ACR-ARS Practice Parameter for Communication3
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity3
A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer3
Emerging Futuristic Targeted Therapeutics3
Proceedings of the American Radium Society® 106th Annual Meeting3
Impact of Coronavirus Disease–era Clinical Trial Reform on Cancer Trial Access in Rural/Underserved Regions of the Mid-West3
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials3
Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis3
Stereotactic Body Radiotherapy for Prostate Cancer3
Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?3
First-line Immunotherapy for Metastatic Merkel Cell Carcinoma3
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer3
Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab3
Matched-pair Analysis for Survival Endpoints Between Women With Early-stage Uterine Carcinosarcoma and Uterine Serous Carcinoma3
Long-Term Outcomes after Abdominal Radiation for Wilms Tumor3
Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer3
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States3
Stereotactic Radiosurgery for Vestibular Schwannoma With Radiographic Brainstem Compression3
Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy3
Management Strategies and Outcomes in Primary Liver Angiosarcoma3
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases3
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients3
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer3
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer3
Flap Reconstruction Results in Longer Overall Treatment Time in Patients Treated with Surgery and Adjuvant Radiotherapy for Carcinoma of the Oral Cavity and Larynx3
Mortality Patterns of Esophageal Cancer in the United States3
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer3
Sentinel Node Navigation Surgery for Early Gastric Cancer3
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer3
Third-line Treatment for Metastatic Triple-negative Breast Cancer3
Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma3
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma2
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma2
Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors2
ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy2
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation2
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant2
Trends and Outcomes of Salvage Lobectomy for Early-stage Non–Small Cell Lung Cancer2
Laparoscopic Versus Abdominal Radical Hysterectomy2
Prostate Brachytherapy With Cs-1312
Cardiac Metastatic Tumors2
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer2
Preliminary Analysis of Cervical Cancer Immunotherapy2
A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms2
Predictors of an Academic Career in Radiation Oncology 5 to 10 Years After Residency2
Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer2
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non−Small Cell Lung Cancer2
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy2
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum2
Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment2
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer2
Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer2
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes2
A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non–Small Cell Lung Cancer2
Radiographic Response of Solitary Plasmacytomas After Conformal Radiotherapy May Be Delayed2
The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-3182
Radiation Oncology Patients Deserve a Doctor2
Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With Cancer2
Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique2
Severe Immune Checkpoint Inhibitor Toxicity Leading to ICU Admission in Patients With Solid Tumors2
The microRNA-34 Family and Its Functional Role in Lung Cancer2
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer2
Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?2
The Efficacy and Safety of Pazopanib Plus Chemotherapy in Treating Recurrent or Persistent Ovarian Cancer2
Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer2
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer2
Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer2
Factors Affecting Inpatient Mortality and Length of Stay in Nonmetastatic Colorectal Cancer2
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy2
Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy1
The Immunosuppression of Etoposide Deserves Attention in Chemoimmunotherapy1
The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer1
A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers1
Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer1
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System1
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer1
The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma1
Lung Metastasectomy in the Treatment of Rectal Cancer Gives Little if Any Benefit Compared With the Importance of Control at the Primary Cancer Site1
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model1
Management Strategies for Patients With Epithelioid Hemangioendothelioma1
Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical Candidates1
Microbiome and Abdominopelvic Radiotherapy Related Chronic Enteritis: A Microbiome-based Mechanistic Role of Probiotics and Antibiotics1
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy1
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients1
Hypofractionated Radiation Therapy1
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer1
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients1
Extraskeletal Myxoid Chondrosarcoma1
Long COVID in Cancer1
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases1
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors1
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma1
The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy1
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction1
Characteristics and Outcomes of Cancer Patients With Venous Thromboembolic Events After Treatment With Immune Checkpoint Inhibitors1
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors1
Advancements in NSCLC1
Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non–small Cell Lung Cancer Patients1
Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma1
The Concerning Disaggregation of Gender and Racial/Ethnicity Disparity Investigation at Recent ASCO Annual Meetings1
Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei1
Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor1
SBRT vs. Y901
Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment1
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer1
Fulfilling the Role of a Parent While Undergoing Treatment for Cancer1
Lower Levels of Trust in the Medical Profession Among White, Younger, and More-educated Individuals With Cancer1
Accelerated Partial Breast Irradiation1
Hospital Price Transparency Rule Exposes Muddied Costs for Head and Neck Radiotherapy in One State1
Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer1
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer1
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer1
ACR–ACNM–ARS–ASTRO–SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals1
Surgical Margins After Neoadjuvant Radiation for Locally Advanced Vulvar Carcinoma1
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba1
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer1
Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer1
Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare1
Metaplastic Breast Carcinoma1
The Prospective Observational Cohort and the Nested Randomized Controlled Trial in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC Study) Question the Reliance on Existing Evidence for the 1
Second Hematologic Malignancies Associated With Primary Mediastinal Germ Cell Tumors1
The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients1
Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction1
Geospatial Mapping of Head and Neck Cancer Research1
Validation of Navigator-Assisted Hypofractionation (NAVAH) Program Survey to Aid American Indian Breast Cancer Patients1
The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies1
Inspiring the Next Generation1
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites1
Multidisciplinary Educational Program to Standardize Education and Management of Immune-related Adverse Events1
Circulating DNA in Rectal Cancer to Unravel the Prognostic Potential for Radiation Oncologist1
Synovial Sarcoma of the Hand and Foot1
Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With 1
Success of Ultra-low Dose Radiation Therapy for Primary Cutaneous B-cell Lymphoma1
MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors1
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity1
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases1
0.10206198692322